Full year group revenue rises 10.5 per cent at NMC Health

Group revenue rose 10.5 per cent to 490.1m dollars in the full year to December 31st at NMC Health, the healthcare provider operating across the United Arab Emirates.

Group revenue rose 10.5 per cent to 490.1m dollars in the full year to December 31st at NMC Health, the healthcare provider operating across the United Arab Emirates.

In a financial report for the full year, the group reported that revenue in the healthcare division was up 15% to $251.6m compared with the full year 2011. This was driven principally by occupancy levels, which were up 750 bps to 60.5% compared with the full year 2011.

Distribution revenue was up 7.0% to $271.1m principally driven by continued expansion of product lines.

EBITDA (earnings before interest, tax, depreciation and amortisation) was up 12.9% to $79.6m compared with the full year 2011.

Business highlights for the year included the completed acquisition of BR Medical Suites in Dubai for a cash consideration of $9.0m. The company was also awarded a five year contract to manage the Sheikh Khalifa General Hospital in Umm Al Quwain.

Dr Shetty, Chief Executive Officer of NMC Health, commented: "This has been a pivotal year for NMC Health, and we are proud to have been the first Abu Dhabi-based business to list on the Premium Segment of the London Stock Exchange.

"Our full year results show that we have made strong progress across our existing facilities during 2012. 2013 will again be a year of transformation as we expect to open three of the four capital projects, which we committed to as part of our IPO, and which will help drive our future growth."

NMC Health's share price was up 0.37% to 270p at 12:43 on Tuesday.

MF

Recommended

Broker safety – your questions answered
Investment strategy

Broker safety – your questions answered

Cris Sholto Heaton answers more of your questions about the safety of stockbroker accounts
25 Mar 2020
How demographics affects stock valuations
Investment strategy

How demographics affects stock valuations

New research suggests that stock and bond valuations are driven by the age of the population – at least in the US.
24 Feb 2020
Do you own shares in Sirius Minerals? Here’s what you need to do now
Stocks and shares

Do you own shares in Sirius Minerals? Here’s what you need to do now

Mining giant Anglo American has proposed a cash takeover of Yorkshire-based minnow Sirius Minerals. Unhappy shareholders must decide whether to accept…
20 Feb 2020
Why investors should be “cautiously bullish” for 2020
Stockmarkets

Why investors should be “cautiously bullish” for 2020

Analysts have been out in force making rosy predictions for stockmarkets in 2020, but while there is certainly a case for optimism, investors should r…
17 Jan 2020

Most Popular

Oil producers are back at their Covid-19 lows – is it time to buy?
Oil

Oil producers are back at their Covid-19 lows – is it time to buy?

With demand for oil hammered by Covid-19 and talk of “peak oil demand”, there are lots of good reasons to be bearish on oil producers. So, asks John S…
22 Sep 2020
The rising dollar is proving bad news for most other assets – will it last?
Investment strategy

The rising dollar is proving bad news for most other assets – will it last?

Precious metals, stocks and pretty much every other asset has taken a tumble as the US dollar strengthens. Dominic Frisby looks at how long this trend…
23 Sep 2020
Why you should stuff your end-of-pandemic portfolio with Chinese stocks
China stockmarkets

Why you should stuff your end-of-pandemic portfolio with Chinese stocks

For an end-of-pandemic portfolio, you need assets that can cope with today’s volatility. And that, says Merryn Somerset Webb, means Chinese stocks.
14 Sep 2020